Quotient Sciences is a CDMO with 30 years of experience in developing formulations across a range of indications. It supports customers across the entire development pathway, from candidate selection to commercial launch. Its innovative approach to formulation development integrates drug product development with clinical evaluation, combined with its experience with over 1,500 molecules at all stages of development. It also offers clinical trial manufacturing, testing and certification services tailored to meet each client’s needs. It operates seven cutting-edge manufacturing and clinical facilities in the UK and the US.